CYP3A4变体对甲在体外代谢中的影响
Chen-Chen Wang1, Ming-Lei Zhang1, Yan-Dan Xu1
1Department of Pharmacy, Quzhou KeCheng People's Hospital, Quzhou, Zhejiang, China.
Biomedical chromatography : BMC
|December 4, 2024
概括
细胞染色体P450 (CYP450) 基因变异会影响甲的代谢. 这项研究评估了22种CYP3A4变体,发现12种减少了甲和3种增加了甲.
科学领域:
- 药物基因组学 药物基因组学
- 药物新陈代谢 药物新陈代谢
- 酶动力学 酶动力学
背景情况:
- 细胞染色体P450 (CYP450) 酶,特别是CYP3A4,对于肝脏药物代谢至关重要,处理超过一半的药物.
- 甲被CYP450酶广泛代谢,使其代谢易受遗传变异的影响.
研究的目的:
- 评估22种CYP3A4等位基变异对甲在体外氧化代谢的催化效率.
- 了解CYP3A4基因多态性如何影响甲的N-脱甲基化和内在清除.
主要方法:
- 利用一个baculovirus-insect细胞表达系统来产生复合CYP3A4变体.
- 通过野生类型 (CYP3A4*1) 和变种CYP3A4酶评估了甲的N-脱甲基化活性.
- 对于每个变异的甲的量化内在清除.
主要成果:
- 十二种CYP3A4变异与野生类型相比,甲的内在清除显着较低.
- 三种CYP3A4变体显示甲的内在清除显著增加.
- 六种变体没有显著差异,而一种变体具有无法检测的表达.
结论:
- CYP3A4基因多态性显著改变了甲的代谢清除.
- 了解这些变异可以指导个性化的甲治疗,并将遗传特征与临床结果联系起来.
相关概念视频
Factors Affecting Drug Biotransformation: Biological
110
Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
110
Factors Affecting Drug Biotransformation: Physicochemical and Chemical Properties of Drugs
185
A drug's physicochemical properties fundamentally influence its metabolism. For instance, a drug's molecular size and shape critically determine its interaction with enzymes and transporters — larger drugs may face difficulty reaching enzyme active sites, altering their metabolic pathways. The pKa of a drug, which establishes its ionization state, can impact its solubility and absorption, thereby influencing metabolism.
The drug's acidity or basicity is essential in...
The drug's acidity or basicity is essential in...
185
Phase II Reactions: Methylation Reactions
134
Methylation is a phase II biotransformation process involving the attachment of a methyl group to a substrate. Enzymes known as methyltransferases orchestrate this reaction.
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
The mechanism of methylation unfolds in two stages. The first stage sees a methyltransferase enzyme facilitating the transfer of a methyl group from S-adenosylmethionine (SAM) to the substrate, forming S-adenosylhomocysteine (SAH). The second stage involves further metabolism of SAH into homocysteine, which can be recycled...
134
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
81
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
81
Drug Metabolism: Phase I Reactions
3.1K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.1K
Drug Biotransformation: Overview
2.3K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.3K


